Since today is Halloween, this blog will commemorate the occasion with a creepy patent. U.S. Patent No. 9,406,092 B2 (‘092) issued on August 2, 2016, for “Targeting items to a user of a social...
As a follow-up to our previous posting on the blockbuster glyphosate trial in which a plaintiff suffering from non-Hodgkin’s Lymphoma was awarded $289 million by a San Francisco jury, the judge, on...
On September 7, 2018, the Court of Appeals for the Federal Circuit decided Worlds Inc. v. Bungie, Inc., representing another case in the growing case law of IPRs and specifically, the time-bar...
The Court of Appeals for the Federal Circuit presented an interesting paradox in patent validity challenges, especially when the same parties bring forth essentially the same issues, but have...
On September 10, 2018, the Court of Appeals for the Federal Circuit decided Orexo AB v. Actavis Elizabeth LLC, in what turns out to be a fairly straightforward analysis of an obviousness case under...
U.S. Patent No. 9,675,579 B2 (‘579) issued on June 13, 2017, for “Tetrahydrocannabivarin for use in the treatment of nausea and vomiting.” It was issued to applicant GW Pharma Ltd., of Salisbury,...
Monsanto Co. is fighting back against the $289 million jury verdict for its glyphosate product, ROUNDUP®. On September 19, 2018, Monsanto filed two post-trial motions for relief with the Superior...
U.S. Patent No. D822,755 S (‘755) issued on July 10, 2018, for “Eyeglasses.” It was issued to inventors Evan Spiegel of Venice, California, Lauryn Morris, of Los Angeles, California, David...
On September 10, 2018, the Court of Appeals for the Federal Circuit decided Regents of the Univ. of Calif. v. Broad Inst., Inc., in the latest court battle in the CRISPR patent challenge pitting...
Another recently unsealed opinion from August 15, 2018 revealed a decision of the Court of Appeals for the Federal Circuit involving inequitable conduct and fee award. In the opinion dated July 28,...